Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma

NCT03782532 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

486

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Dupilumab SAR231893
DRUG: Placebo
DRUG: Asthma Controller Therapies (include prednisone/prednisolone)
DRUG: Asthma Reliever Therapies

Sponsor

Sanofi

Collaborators

[object Object]